Clinical Trials Logo
  1. Home
  2. Hypopharyngeal Cancer
  3. NCT01312350

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Hypopharyngeal Cancer Clinical Trial

Official title:
Concurrent Chemoradiation Versus Induction Docetaxel, Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy in Locally Advanced Hypopharyngeal and Base of Tongue Cancer: A Randomized Phase II Study

Clinical Trial Summary

The investigators will examine whether 2-cycles of DFP chemotherapy before definitive concurrent chemoradiation therapy (CCRT) can improve progression-free survival in locally advanced (Stage III & IVM0) hypopharyngeal and base of tongue carcinoma compared to definitive CCRT alone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01312350
Study type Interventional
Source Samsung Medical Center
Contact
Status Completed
Phase Phase 2
Start date November 2010
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT02113878 - Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck Phase 1
Recruiting NCT03558035 - New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma Phase 2
Completed NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Phase 2
Recruiting NCT04539600 - Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer Phase 2
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Completed NCT03934294 - Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients N/A
Recruiting NCT01516996 - Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer Phase 2
Withdrawn NCT01175499 - Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract N/A
Recruiting NCT05860335 - Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer Phase 2
Completed NCT00473564 - Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery N/A
Recruiting NCT06039631 - Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer Phase 2
Not yet recruiting NCT00302562 - The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma N/A
Recruiting NCT00174096 - The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma N/A
Recruiting NCT00173381 - The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis N/A
Recruiting NCT05894070 - The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
Recruiting NCT04502641 - Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial Phase 3
Recruiting NCT05420597 - Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma Phase 2